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Ionomic proﬁling of pericardial ﬂuid in ischemic
heart disease†
Noman Khan,a Satwat Hashmi,b Amna Jabbar Siddiqui,c Sabiha Farooq,a
Shahid Ahmed Sami,d Nageeb Basir,e Syeda Saira Bokhari,e Hasanat Sharif,d
Sanaullah Junejof and Syed Ghulam Musharraf *ac
Metals are essential cofactors that play a crucial role in heart function at the cell and tissue level. Information
regarding the role of metals in the pericardial ﬂuid and its ionome in ischemic heart disease (IHD) is limited.
We aimed to determine the association of elements in pericardial ﬂuid and serum samples of IHD patients
and their correlation with systolic and diastolic function. IHD patients have been studied with systolic and
diastolic dysfunction categorized on the basis of echocardiographic parameters. We measured
concentrations of sixteen elements in the pericardial ﬂuid and serum of 46 patients obtained during
open heart surgery with IHD by ICP-MS. The levels of chromium and nickel in pericardial ﬂuid were
signiﬁcantly higher as compared with serum samples of IHD patients (p < 0.05). The chromium, nickel
and manganese levels in pericardial ﬂuid were lower in patients with ejection fraction (EF) < 45% as
compared to EF > 45% (p < 0.05). There was no signiﬁcant diﬀerence in pericardial concentrations of
elements in diastolic dysfunction grade 0–1 with 2 in IHD patients. We also found that decreased
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concentration of these elements in pericardial ﬂuid is associated with decreased systolic function. These
results suggest that pericardial ﬂuid concentrations of these metals may reﬂect the extent of ischemic
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heart disease. These ﬁndings are hypothesis generating with regards to a role in the pathogenesis of the
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disorder.

Introduction
Micronutrients are essential cofactors needed only in small
amounts for energy transfer in cells and thus play a crucial role
in heart function at the cell and tissue level.1 These metals play
role as regulators of oxidative stress, as antioxidants and as
regulators of inammatory response and immune cell activity.2
There is emerging evidence suggesting an important role of
trace elements like chromium, zinc, cobalt, selenium, manganese and nickel in the heart and that their homeostasis
imbalance may lead to an increase in the risk of cardiac
remodelling in heart failure.3 Studies have shown that these
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micronutrients are intricately linked to Ischemic Heart Disease
(IHD).4–7 It is well established that IHD is a global health issue
and the major cause of mortality and morbidity worldwide.8,9
IHD is an important risk factor for the development of
systolic and diastolic dysfunction of the heart and is intricately
linked to their pathophysiology.10–12 Systolic dysfunction refers
to the impaired pump function of the heart, whereas diastolic
dysfunction refers to the increased resistance to lling of the
heart with increased lling pressures.13 Echocardiography is
a non-invasive method to assess the systolic as well as diastolic
function or dysfunction.13 Systolic dysfunction is assessed by
estimation of the ejection fraction (EF) and regional wall
motion, whereas diastolic dysfunction can be diagnosed indirectly by means of a normal or nearly normal EF and changes of
the mitral lling pattern.13 Several studies have shown that
systolic or diastolic dysfunction, even if asymptomatic, may be
a precursor to symptomatic heart failure which is linked to
increased mortality.14,15 Recent guidelines also place special
emphasis on the detection of subclinical le ventricular systolic
and diastolic dysfunction and timely identication of risk
factors.16
Pericardial uid (PCF) is a dynamic and composite biological serous uid, present within the pericardial cavity
surrounding the heart uids.17,18 This uid is derived by
plasma ultraltration through the epicardial capillaries and
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interstitial uid from the underlying myocardium during the
cardiac cycle.19 PCF is therefore in a strategic position to
provide important information regarding the pathologies that
distress the pericardial space as well as the heart itself. Studies
in greyhounds have shown that the concentrations of sodium,
chloride, calcium and magnesium were lower in the pericardial uid than in the plasma. On the contrary, the concentration of potassium was higher than the plasma, which was
attributed to the potassium leakage from the myocardial
interstitium toward the pericardial cavity, during systole.20,21
The current research work on the redox nanomaterial was
done on the ischemia heart disease, such as cerium oxide
nanoparticles (nCe) have been used extensively, possess
oxygen-modulating properties which have shown therapeutic
utility in various disease models.22,23
Ben-Horin et al.24 had studied the composition of pericardial uid in patients with elective open heart surgery but there
is no study which reported the in-depth analysis of the PCF
ionome particularly in IHD patients. This study is aimed to
identify ionomic proles of PCF and their paired serum
samples in IHD patients with systolic and diastolic dysfunction. Identication and quantication of common and diﬀerential elements in these two biological uids may be helpful in
understanding the mechanism of disease development and
thus ultimately prove helpful in devising interventions to delay
the progression of IHD to heart failure by its early
characterization.

Table 1

Paper

Material and methods
Patient's selection and classication
Patients with conrmed IHD were admitted for coronary artery
bypass graing (CABG); and were selected for this study aer
informed consent. The study was approved by the Institutional
Review Board (IRB) of ICCBS and the Ethics Review Committee
(ERC) of the Aga Khan University. Pericardial uid and blood
samples were collected at the time of CABG procedure. Echocardiographic assessment of systolic and diastolic function and
le ventricular (LV) morphology was done before start of the
procedure and reported according to the American Society of
Echocardiography (ASE) 2009 guidelines.
Patients were classied into diﬀerent categories according to
ejection fraction (EF < 45% and EF > 45%) for systolic function
assessment; and in grades (0–1 and 2) for diastolic dysfunction
as depicted in Table 1. In normal heart, EF is between 50 and
70%. In our study, EF < 45% is referred to as reduced ejection
fraction and EF > 45% indicates preserved ejection fraction.
Diastolic dysfunction grades were of three types which
include grade I (impaired relaxation of LV with or without
increased in lling pressure), grade II (moderate increase in LV
lling pressure with pseudo-normalization of LV) and grade III
(marked increase in lling pressure with restrictive LV
lling).25,26 Patients with malignancy, constrictive pericarditis
and inltrative, established pulmonary disease, renal insuﬃciency, moderate to severe valvular disease, hypertrophic

Clinical characteristics of study patients with IHDa

Patient characteristics

Serum samples

PCF samples

Number of samples
Gender (male/female)
Age male (years; m  s)
Age female (years; m  s)
Height (cm)
Body weight (kg)
BMI (kg m2)
SBP (mm Hg)
DBP (mm Hg)

62
54/8
59  8
58  10
164  9
72  12
27  5
129  19
76  9.69

46
44/2
58  7
65  11
166  6
75  12
27  4
130  21
77  11

Medical history
Diabetes/non-diabetes
Hypertension/non-hypertension
Chest pain/non-chest pain
Current smoker/non-smokers
Hypercholesterolemia/non-hypercholesterolemia

Frequency
37/25
41/21
48/14
11/51
6/56

25/21
29/17
32/14
6/40
5/41

Echocardiographic parameters
Ejection fraction (N; <45%/>45%)
Diastolic dysfunction grade (N; 0–1/2)

12/50
45/9

12/34
36/5

Biochemical parameters
Creatinine (mg dL1)
BUN (mg dL1)
Random blood glucose (mg dL1)
Fasting blood glucose (mg dL1)

0.99  0.26
18  8
184  65
165  58

1.06  0.26
17  7
199  61
169  56

a

m; mean, s; standard deviation, BMI; body mass index, SBP; systolic blood pressure, DBP; diastolic blood pressure, BUN; blood urea nitrogen.
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cardiomyopathies and metabolic bone diseases were excluded
from the study.
Sample collection and processing
The approved protocol from review board was followed for
collection and storage of blood and PCF samples. 4 mL of blood
sample was collected by the help of BD® Vacutainer tubes based
on gel (BD Franklin Lakes NJ, USA, ref: 367381) from the
patient. The serum samples were separated immediately by
centrifugation at 2000 rpm for 10 min at 4  C. Aer centrifugation, serum was aliquoted into locking Eppendorf tube stored
at 80  C until processing. Pericardial uid was collected in
clean and sterile falcon tubes. These tubes were centrifuged for
about 15 min at 3500 rpm. The clear supernatant was collected
and stored at 80  C until further processing.
Reagents and standards
Extremely pure de-ionized water (resistivity 18.2 MU cm) was
obtained from a Milli-Q water purication system (Thermo
Fisher Scientic, MA USA). All reagents used during the study
were of analytical grade. Trace metal grade $ 30% (v/v)
concentrated H2O2 was obtained from Merck KGaA Company
(Darmstadt, Germany). 70% (v/v) concentrated HNO3 (RCI
Labscan Ltd, Bangkok, Thailand) was used during analysis aer
purication with NanoPure acid purication system (Nanonex,
USA). Multi-element calibration standard (part number: 85006940) with concentration (10 mg mL1) of each element, the
tuning solution (1 mg L1) concentration of Mg, Li, Tl, Y, Co and
Ce in 2% (v/v) HNO3 and internal standard (Sc, Bi, Ir, Lu, Ge, Rh
and Tb) of concentration (100 mg mL1) were acquired from
Agilent Analytical Technologies Company (Santa Clara, CA,
USA). The optimization of ICP-MS was carried out by using
tuning solution. All glassware, polypropylene tubes and bottles
were acquired from Agilent Technologies (Santa Clara, CA,
USA). All tubes and bottles were immersed overnight in 10% (v/
v) HNO3 and cleaned by rinsing three times with high purity
deionized water and kept in laminar-ow hood (Airstream®
ESCO, Singapore) to dry. All operations were in a clean hood
and working table to avoid of air contaminant postulate.
Preparation of standard solutions
To prepare all solutions, 5% (v/v) nitric acid was used as matrix.
A total of sixteen points calibration curves (0.0076–1000 mg L1)
were prepared. A blank was also prepared with same matrix. The
sensitivity was measure by least-square regression equation.
The standard solution was also used for the validation of
current study by calculating LOD, LOQ and correlation
coeﬃcient.
Preparation of the standard reference material
Certied reference material Seronorm™ serum L-1 (Sero, Billingstad, Norway) was use for validation of method. The validation was accomplished by precision and accuracy. The certied
reference material (CRM) was prepared as per the manufacturer
protocol. Briey, the contents vial were completely dissolved by

This journal is © The Royal Society of Chemistry 2020
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the addition of 3 mL of high purity de-ionized water. The vial
content was smoothly rolled for 30 min so that all the contents
were mixed entirely. The total quantity of material was transferred to polypropylene tubes and further diluted with sterile
deionized water. The diluted solution was nally analyzed for
each trace and ultra trace element through ICP-MS. The CRM is
most used for serum but there is no standard reference material
available for pericardial uid to check the concentration of
metals.
Sample preparation for ICP-MS
The digestion of serum and pericardial uid were carried out in
a closed vessel sealed microwave system equipped with 64MG5T64 rotor (Anton Paar GmbH, Austria). In the microwave
system, the program with multiwave ECO soware (version
1.51) was setup. The standard apparatus such as polytetrauoroethylene (PTFE) lip seal tube and screw cap (Wheaton® 15
 45 mm, cap 13-425) were used during analysis.
For digestion of samples, a total of 50 mL aliquot of every
sample was taken (serum and pericardial uid), added in the
MG5 vials (Anton Paar, Hungary). 50 mL of $30% (v/v) H2O2 and
150 mL of 70% (v/v) HNO3 were also added, mixed, and kept in
laminar fuming hood for 10 minutes so that fumes were evolve.
Vials were sealed with the PTFE lip and screw cap. Sealed vials
were placed in microwave digestion system. The samples were
digested in two steps via regulating same parameters in Anton
Paar microwave digestion system with same fan (1), ramp (10.0
min), hold (30.0 min), power (850 W), stir rate (medium) but the
temperature set 90  C for step 1 while 150  C for step 2. Aer the
completion of digestion all sample vials were kept in laminar
hood and allowed to cool at room temperature. Then gently
pierced the septa by steal pin to release pressure of gas in vials,
the resultant samples were took into 15 mL of polypropylene
tubes and diluted with 3 mL of high purity deionized water. All
samples were analyzed in triplicate on ICP-MS instrument.
Inductive coupled plasma-mass spectrometry (ICP-MS)
analysis
The quantication of trace and ultra-trace elements were
carried by Agilent 7700x ICP-MS system (version B.01.01) (Santa
Clara, CA USA). The 7700x ICP-MS was improved with 1600 W
power and it was operated at 27 MHz radio frequency (RF). To
remove contamination from ICP-MS, washing solution containing ultra-pure water, 2% (v/v) HNO3 and 0.1% (v/v) HCl was
analyzed aer each sample. The Mass Hunter soware was used
for the operation of ICP-MS data. The acquisition parameter of
Agilent 7700x ICP-MS are given in the ESI Table S1.†
ICP-MS data pre-processing and statistical analysis
The fully licenced Mass Proler Professional (MMP) soware
were purchased form Agilent (Santa Clara, CA, USA) and used
for data pre-treatment and statistical analysis. Filtering of the
data involved using all available data and minimum absolute
abundance of 10 000 counts with 3 number of ions/fragments
minimum. Match factor 0.3, retention time tolerance 0.05 and
delta MZ (low resolution) 0.2 were set as alignment parameters.

RSC Adv., 2020, 10, 36439–36451 | 36441

View Article Online

Open Access Article. Published on 02 October 2020. Downloaded on 9/23/2021 12:13:08 PM.
This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

RSC Advances
External scalar was used for normalization of data. In this
method of normalization, for lth samples an external scalar
value “Sl” is subtracted from the abundance value “Ml” using
the formula: normalized abundance ¼ log2 Ml  log2 Sl. Z
transform was selected as base lining option treating all the
compounds equally irrespective of their intensity. Aer alignment of the data, entities were ltered by frequency (i.e.
compounds appearing in more than 50% of samples in at least
one group of samples).
Statistical analyses were carried out on PCF and serum
samples of ischemic heart disease patients which were categorized on the basis of ejection fraction (<45% and >45%) as
diastolic dysfunction and diﬀerent grades (0–1 and 2) as systolic
dysfunction. The statistical analysis was done by Mann–Whitney unpaired test for comparing two diﬀerent groups. The pvalue computation was done by asymptotically method and
multiple test correction by Benjamini–Hochberg FDR. The
analyzed variables with corrected p-value cut-oﬀ < 0.05 and fold
change (FC) > 1.5 were selected as signicant variables
throughout the analysis.
SIMCA MKS Umetrics AB (version 14.1) soware was used for
multivariate analyses such as principal component analysis
(PCA), partial least squares discriminant analysis (PLS-DA) and
orthogonal partial least squares discriminant analysis (OPLSDA) and their loading plots, which show overview, relation
between the two groups of variables, class discrimination and
variable correlation, respectively.

Method validation and data quality assessment
The concentration range 0.0076–1000 mg L1 was selected for all
elements to obtain linear calibration curve plot. The plot
between concentration and count per seconds for each element
was analysed by regression methods. The method of quantication was validated by limit of quantication (LOQ), correlation coeﬃcients (R2) and limit of detection (LOD). The obtained
correlation coeﬃcients (R2) for all the element were in range of
0.993 and 1.000, shows good linear relationship. The formula of
LOQ ¼ 10s/S and LOD ¼ 3.3s/S were used, where (S) is the slope
and (s) is standard deviation of the regression line. The range
0.002–9.551 mg L1 and 0.006–28.941 mg L1 were obtained for
the optimized method for LOD and LOQ, respectively. The R2,
LOD, LOQ values and regression equations are shown in ESI
Table S2.†
The developed method was also validated externally to check
the accuracy and precision for elements analysis in biological
uid by using Seronorm™ trace elements serum L-1 as certied
reference material (CRM). The obtained data was found with
nonsignicant variation and calculated value agrees with the
theoretical certied values. The range of 81.879–113.779% were
obtained for the percent recovery as shown in ESI Table S3.†
The spiking experiment were performed in real samples of
serum and pericardial uid for the validation of current method
in order to check the precisions (RSD, %) and reliability. The
precision of the developed method was calculated by RSD, % ¼
[SD/CM]  100, whereas SD and CM stands for standard deviation and measured mean concentration of elements. The
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percent RSD was found to be below 10%. The obtained coeﬃcient of variation (% RSD) for the present method was in range
of 0.052–7.580 and 0.076–5.733 for serum and pericardial uid,
respectively as given in the ESI Table S4.† This result shows the
accuracy with good precision and sensitivity of our method.

Results
Ionomic prolling of pericardial uid and serum for IHD
patients
In this study element analysis was carried out through the ICPMS for pericardial uid and serum samples of the IHD patients.
Signicance testing was conducted on a total of 16 elements.
From these, 14 elements were found to show signicant
diﬀerences at a probability level of <0.05. Out of these 14
elements, the concentration of twelve elements (copper, zinc,
aluminum, manganese, lithium, cobalt, calcium, lead, silver,
cadmium, selenium and arsenic) were higher while chromium
and nickel were lower in serum samples in comparison to PCF
samples of IHD patients as listed in Table 2. The heatmap of all
signicant elements with averaged normalized intensity of two
groups is mentioned in ESI Fig. S1.†
For further data mining, multivariate analysis was performed. The PCA was rst performed in order to obtain a trend
of separation of samples (Fig. 1A). This plot showed two
components with value of R2X 0.376 and 0.167 on x-axis and yaxis, respectively. The score plot showed the outliers with
condence limit of 95% by Hotelling's T2-test, hence outliers
were removed before further analyses. There are clear diﬀerences related to serum and PCF samples of IHD patients
observed in PCA analysis. For classication analysis on groups,
PLS-DA and OPLS-DA models were also generated by using
normalized concentrations of signicant elements. Both 3D
score plot showed strong separation between two diﬀerent
biouids (Fig. 1B and C).

List of elements in pericardial ﬂuid of IHD patients that are
signiﬁcantly diﬀerent from serum of IHD patients. Mann–Whitney
unpaired t-test was used with Benjamini–Hochberg FDR p-value
correction method. Elements with p-value < 0.05 and fold change (FC)
> 1.5 were referred as signiﬁcant variables

Table 2

Elements

p (corr)

log FC
(PCF IHD/SR IHD)

60

1.23  103
2.24  102
7.71  104
2.45  105
3.79  105
8.78  107
6.02  107
8.08  108
5.10  1018
1.00  1022
1.00  1027
1.59  1028
3.39  1034
0.00  100

0.6289
0.4514
0.6560
0.7132
0.7945
0.9292
0.9446
1.0070
1.4472
1.5683
1.6657
1.6806
1.7604
1.9128

Ni
Cr
63
Cu
66
Zn
27
Al
55
Mn
7
Li
59
Co
44
Ca
208
Pb
107
Ag
111
Cd
78
Se
75
As
52

This journal is © The Royal Society of Chemistry 2020
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Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot colored as a function of VIP of serum (SR)
(green) and pericardial ﬂuid (PCF) from ischemic heart disease (IHD) (blue).

Fig. 1

The sensitivity and specicity for the generated models were
calculated as the number of diseases samples predicted as true
positive divided by total number of disease samples and
number of referents predicted as true negative divided by total
number of referents, respectively. The models of PLSDA and
OPLSDA shows 100% specicity, sensitivity and classication
rate.
The model of OPLSDA was validated by ROC plot (ESI
Fig. S2†) and permutation (ESI Fig. S3†); which showed least
diﬀerence between predictive ability and goodness of t of
model with good area under the curve. In the OPLSDA loading

Table 3 List of elements in PCF of patients with EF > 45% and EF < 45%
that are signiﬁcantly diﬀerent. Mann–Whitney unpaired t-test was used
with Benjamini–Hochberg FDR p-value correction method. Elements
with p-value < 0.05 and fold change (FC) > 1.5 were referred as
signiﬁcant variables

Elements

p (corr)

log FC
(PCF EF < 45%/PCF EF > 45%)

52

0.026399003
0.026399003
0.016587258

0.1544
0.1691
0.2560

Cr
Mn
60
Ni
55

This journal is © The Royal Society of Chemistry 2020

plot (Fig. 1D), it is observed that elements like arsenic, silver,
cadmium and lead is most responsible for group
discrimination.
Ionomic prolling of pericardial uid and serum for IHD
patients with systolic dysfunction
The element concentrations studied in the pericardial uid of
patients with systolic dysfunction is based on the two groups,
EF < 45% and EF > 45%. Table 3 shows signicant metals in
pericardial uid based on groups EF < 45% and EF > 45%. It was
found that only three metals, that are chromium, manganese
and nickel, are statistically signicant. These three metals are
higher level in group EF > 45% as compared to EF < 45%. It
seems that level of these metals is decreased as the ejection
fraction reduces.
Based on the normalized concentration of elements, PCA
score plot in Fig. 2A did not show clear separation on the basis
of ejection fraction. However, at 95% condence limit from
Hotelling's T2-test resulted in few outliers. The rst component
at x-axis gave more variance with the value of R2X 0.245 while
the second component is 0.198. For class discrimination, all
variables were used to perform PLSDA as shown in Fig. 2B. It
was found that 3D-PLSDA score plot showed that samples were

RSC Adv., 2020, 10, 36439–36451 | 36443
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Fig. 2 Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot of pericardial ﬂuid in patients with EF > 45%
(green) and EF < 45% (blue).

widely scattered and clear trend of separation in IHD patient
with EF > 45% and < 45%. Addition of another orthogonal
projection to the above model (Fig. 2C) did not aﬀect the
sensitivity and specicity of OPLS-DA model considerably. In
loading plot, variables were arranged according to their
performance for discrimination among the groups in the OPLSDA model. Fig. 2D showed that nickel and manganese are
mainly responsible for group separation.
The statistical analyses of two diﬀerent biouids (PCF and
serum) of IHD patients were carried out. We have also
compared the data of paired samples of EF > 45% of IHD
patients. It was found that out of sixteen elements, list of 14 was
generated at probability of <0.05 in EF > 45% of pericardial uid
and serum samples of IHD. Out of fourteen elements zinc,
copper, manganese, aluminum, cobalt, lithium, calcium, lead,
cadmium, silver, selenium and arsenic were higher in concentration, while chromium and nickel were lower in PCF as
compared to serum of IHD patients with EF > 45% as listed in
Table 4.
The plots were drawn on the basis of normalized concentration of elements in serum and pericardial uid of IHD

36444 | RSC Adv., 2020, 10, 36439–36451

Table 4 List of elements in pericardial ﬂuid that are signiﬁcantly
diﬀerent from serum of IHD patients with EF > 45%. Mann–Whitney
unpaired t-test was used with Benjamini–Hochberg FDR p-value
correction method. Elements with p-value < 0.05 and fold change (FC)
> 1.5 were referred as signiﬁcant variables

Elements

p (corr)

log FC
(PCF EF > 45%/SR EF > 45%)

60

1.06  104
0.0093986
0.002758518
5.19  105
0.005190234
1.16  104
4.02  105
5.68  1014
3.68  109
3.03  1013
5.68  1014
4.08  1013
5.16  1013
5.68  1014

0.6999
0.6493
0.5061
0.5391
0.6625
0.8279
0.9176
0.9890
1.3989
1.6140
1.6268
1.6297
1.7894
1.9070

Ni
Cr
66
Zn
63
Cu
55
Mn
27
Al
59
Co
7
Li
44
Ca
208
Pb
111
Cd
107
Ag
78
Se
75
As
52

This journal is © The Royal Society of Chemistry 2020
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Fig. 3 Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot colored as a function of VIP of serum (SR) EF >
45% (green) and pericardial ﬂuid (PCF) EF > 45% from ischemic heart disease (IHD) (blue).

patients with EF > 45%. The overview of samples can easily be
seen with outliers at 95% condence limit that generated from
Hotelling's T2-test in PCA score plot (Fig. 3A). It was observed
that component on x-axis R2X [1] 0.368 gave more variance as
compared to R2X [2] 0.188. 3D PLSDA (Fig. 3B) and OPLSDA
(Fig. 3C) score plots for showed clear trend of separation,
distinction and discrimination between the EF > 45% groups.
For the PLSDA and OPLSDA the sensitivity, specicity and
classication rate were found to be 100%. Four elements, lead,
cadmium, silver and arsenic were mainly accountable for group
diﬀerentiation as shown in the VIP loading plot of OPLSDA
(Fig. 3D).
This type of comparison was performed as paired samples of
EF < 45% of IHD patients were available. Out of 16 elements
analyses, eleven elements (lithium, cobalt, copper, lead, zinc,
selenium, calcium, manganese, silver, arsenic and cadmium)
showed statistical signicance. These elements were higher in
serum as compared to PCF in patients with EF < 45% (Table 5).
PCA (Fig. 4A) showed outliers in samples and data was more
scattered. PLSDA (Fig. 4B) and OPLSDA (Fig. 4C) 3D score plot
were also produce and it shows serum and PCF EF < 45% were
clearly separated and diﬀerentiated with each other. However,

This journal is © The Royal Society of Chemistry 2020

the sensitivity, specicity and classication rate of the model
are 100% for all. Lead, cadmium, silver, arsenic, calcium and
manganese are most responsible elements in discrimination of
serum and PCF EF < 45% (Fig. 4D).
Table 5 List of elements that are signiﬁcantly diﬀerent in serum as
compared to pericardial ﬂuid in patients with EF < 45%. Mann–Whitney
unpaired t-test was used with Benjamini–Hochberg FDR p-value
correction method. Elements with p-value < 0.05 and fold change (FC)
> 1.5 were referred as signiﬁcant variables

Elements

p (corr)

log FC
(PCF EF < 45%/SR EF < 45%)

7

1.09  104
2.20  104
0.0015
2.98  105
3.23  105
1.07  104
6.78  105
3.23  105
3.23  105
3.21  105
3.20  105

0.7856
1.2880
1.3165
1.4221
1.6478
1.6500
1.6740
1.6763
1.7608
1.9190
1.9306

Li
Co
63
Cu
208
Pb
66
Zn
78
Se
44
Ca
55
Mn
107
Ag
75
As
111
Cd
59
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Fig. 4 Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot colored as a function of VIP of serum (SR) EF

< 45% (green) and pericardial ﬂuid (PCF) EF < 45% from ischemic heart disease (IHD) (blue).

Ionomic prolling of pericardial uid and serum for IHD
patients with diastolic dysfunction (grade 0–1 and grade 2)

Discussion

Diastolic dysfunction (DD) was determined by echocardiography according to dened criteria in American Society of
Echocardiography (ASE) 2009 guidelines. In the PCA chemometric model of PCF grades, no separation trend in PCA was
observed. This could possibly due to less number of samples
in higher grades (Fig. 5A). The PLSDA and OPLSDA (Fig. 5B
and C, respectively) models do not show visual separation of
PCF grades of IHD patients. Due to less number of samples at
higher grades of disease, it is unable to generate a specic
model as required. It was found that PLSDA model showed
100% sensitivity and 40% specicity. In the loading plot of
OPLSDA three elements were responsible for group discrimination, which were iron, manganese and cadmium (Fig. 5D).
No element was found to be statistically signicant while
comparing grades of PCF with serum grades. Hence, further
analyses related to parallel grades of PCF and serum were not
performed.

Our study is reporting quantication of metals (trace elements)
in pericardial uid and their comparison with serum levels in
samples of patients with ischemic heart disease its correlation
with severity of disease categorized on the basis of their systole
function (i.e. EF < 45% and EF > 45%) and diastolic function
(DD grades 0–1 and 2).
The results show clear image of elements that are diﬀerently
regulated in IHD patients with systolic and diastolic dysfunctions. Our results describe the comparison of paired samples of
pericardial uid and serum of IHD patients.
We demonstrated that the level of chromium and nickel
were higher in pericardial uid, whereas, copper, zinc,
aluminum, manganese, lithium, cobalt, calcium, lead, silver,
cadmium, selenium and arsenic were lower in PCF of IHD
patients when compared with their serum. Like other serosal
uids, pericardial uid is believed to be a transudate created as
a result of net hydrostatic pressure and osmotic gradient
between pericardial uid and plasma,24 but there is paucity of
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Fig. 5 Scores scatter plots (A) PCA, (B) 3D PLS-DA, (C) 3D OPLS-DA and (D) OPLS-DA loadings plot of pericardial ﬂuid with DD grade 0–1 (green)
and DD grade 2 (blue) of diastolic dysfunctions.

data regarding the concentration of these micronutrients in the
pericardial uid.
Our study found that the level of chromium, nickel and
manganese are higher in the PCF of patients with EF > 45 as
compared to EF < 45. When the pericardial uid was analyzed
for diastolic dysfunction grades, the results were not conclusive.
Chromium is important for various functions in the body,
a major role is in the metabolism of lipid and carbohydrate.27
Chromium is involved in insulin signaling and promotes
enhancement of insulin sensitivity, a role well recognized in
reducing the risk of cardiovascular diseases and type 2 diabetes.28 It is also important in the maintenance of glucose
tolerance and redox reaction in the cell.29,30 It has been
demonstrated that chromium inhibits the glycosylation of
proteins and oxidative stress in erythrocytes,31 both risk factors
in the development of cardiovascular diseases. Studies have
shown that chromium reduced systolic blood pressure and
ameliorated insulin resistance in both animals and human
subjects.32,33 It has been reported that chromium concentrations in the blood stream are lower in patients with coronary

This journal is © The Royal Society of Chemistry 2020

artery disease than in subjects with normal arteries34 which
suggested that a risk factor for cardiovascular disease might be
chromium deciency.35
The essential role of nickel consists of the action or formation of cyclic guanosine monophosphate, a signaling agent that
regulates various physiological processes including blood
pressure control, sperm physiology, sodium metabolism among
many others.36 In animals, nickel deciency inhibits growth,
reduces reproductive rates, and alters glucose and lipid
metabolism that are associated with anemia, hemoglobin
reduction, alternations of metal ion contents, and reduced
activity of several enzymes.37,38 Toxic exposure to nickel,
however, can cause cardiac dysfunction due to reactive oxygen
and free radical cellular damage.39 Ni ions have been reported to
induce vasoconstriction and early aer depolarization in isolated rat heart and canine coronary artery by enhancing Ca ion
inux into vascular smooth muscle cells.40–42
Chromium and nickel were found as signicant element in
this study, however, from the bio-inorganic chemistry eld
there is no clear evidence of the biological role of these elements
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in humans (or mammals), although for nickel the biological
role in bacteria, archaea, fungi and plants is well established as
mentioned in the above paragraphs. Obviously, these elements
are present in the environment and will occur in biological
samples as contaminants. Furthermore, it is clear that various
ions of chromium or nickel have toxic (and allergic) eﬀects that
are well described.43–45 Hence it suggests that these elements in
IHD patients might be a source of contamination.
Manganese was also found to be signicantly higher in PCF
of patients with EF > 45%. Manganese, another trace element,
is a vital and an essential part of many enzyme systems46 e.g.,
superoxide dismutase, succinate dehydrogenase, glutamine
synthetase, diamine oxidase, arginase, pyruvate carboxylate
and phosphoglucomutase.47 Manganese is particularly
important in superoxide dismutase and adenylyl cyclase, the
two antioxidant enzymes ghting oxidative stress in the
body.48 It plays a crucial role in the vascular contractility and
low level of manganese resulted in decreased superoxide dismutase eﬀect.49 Manganese plays important role in the
cholesterol metabolism, oxidative phosphorylation, fatty
acids, urea cycle and mucopolysaccharide metabolism.50 Many
metabolic processes are carried by metalloprotein and metal
binding proteins; the metals, manganese, nickel, iron,
magnesium and zinc work as cofactors.38,51 Studies have
shown that the serum levels of manganese are lower in
patients with atherosclerosis and it decreases with the severity
of the disease,52 however, some conicting reports indicate
that high level of manganese was observed in coronary artery
disease as compared to healthy subjects.53 A study done on the
aortic tissue of normal as well as atherosclerotic patients,
showed low level of manganese, however there was no information related to cause and eﬀect.54
This is interesting to note that in the group of IHD patients
with EF > 45% the PCF had higher levels of chromium, nickel
and manganese as compared to the group with EF < 45%
(Fig. 2). If PCF of EF > 45% was compared with serum of EF >
45% we found higher levels of manganese and lower levels of
chromium and nickel in the PCF compared to serum of patients
with EF > 45% (Fig. 3). If PCF of EF < 45% is compared with
serum of patients with EF < 45%, we found that only manganese
was lower in PCF, the other two metals failed to show any
signicant association (Fig. 4).
We do not know why pericardial uid levels and serum levels
are showing diﬀerent trends of up and down regulation of these
metals. The only link we seem to nd which is substantiated by
previous work is that pericardial uid chromium, nickel and
manganese levels fall with decreasing ejection fraction which
corresponds to the severity of the disease. We also found that
the concentration of chromium and nickel were lower in serum
as compared to PCF of IHD patients with EF > 45% and chromium and nickel were not picked up in the analysis of PCF and
serum of patients with EF < 45% (Fig. 5).
We can say that chromium and nickel together are present in
signicantly higher levels in patients with EF > 45% as
compared to EF < 45% and this is reected in the PCF more
strongly than serum.
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Conclusion
Our study has shown that pericardial concentrations of essential trace element chromium, nickel and manganese were
signicantly higher in the IHD group than in the serum of IHD
patients. We also found that concentration of these elements in
pericardial uid is associated with decreased systolic function.
These results suggest that pericardial uid concentrations of
these metals may reect the extent of ischemic heart disease
and may also play a role in the pathogenesis of the disorder. As
the pericardial uid cannot be obtained from normal subjects,
hence no information is available for the physiological
concentrations of these metals. We only had a few cases of
advanced diastolic dysfunction so it may be postulated that our
study lacked the power to detect a diﬀerence in ionome in
diastolic dysfunction. However, the present results indicate that
pericardial uid, once it is obtained, maybe a useful source for
examining the severity and extent of coronary artery disease.
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